BETA
Your AI-Trained Oncology Knowledge Connection!
Neoadjuvant Therapy Trumps Surgery in NSCLC Debate
The University of Chicago goes against Northwestern Medicine to see who will be crowned the winner in the NSCLC debate.
Dato-DXd: A Path to Potential Approval in NSCLC
Experts discussed the advancements in non–small cell lung cancer treatment and developments in both antibody-drug conjugate–based approaches and targeted therapies.
Optimizing AE Management Post CAR T-Cell Therapy in Multiple Myeloma
Experts spoke about the best practices for mitigating adverse effects associated with CAR T-cell therapy in relapsed/refractory multiple myeloma.
Long-Term Data Affirm Enduring Responses With Teclistamab in R/R Multiple Myeloma
Amrita Y. Krishnan, MD, and Binod Dhakal, MD, gave a high-level overview of teclistamab use in the MajesTEC-1 trial.
Exploring GPRC5D as an Important Target for Multiple Myeloma
Experts highlighted the use of GPRC5D therapy in patients with multiple myeloma.
